Bioresorbable Implants Market - Size, Share, Trends, and Forecast, 2022 - 2028

Bioresorbable Implants Market - Size, Share, Trends, and Forecast, 2022 - 2028

Bioresorbable implants are prosthetic in nature and are made from polymer having a property to gradually decompose with the passage of time. It is used to support, enhance, and regularize the physiological function in the human body. Different types of material used in bioresorbable implants are Poly lactic-co-glycolic acid (PLGA), Poly L-lactide (PLLA), and others. The PLGA bioresorbable implant are actively used in periodontal therapy.
Market Dynamics
Increasing prevalence of trauma injuries, osteoporosis, and cardiovascular diseases is a major factor driving bioresorbable implants market growth. According to World Health Organization (WHO) factsheet in 2018, annually there are around 37.3 million falls, which require medical attention whereas an estimated 646,000 individuals die annually from falls globally. Moreover, advantages of bioresorbable polymer implants over metallic implants are expected to boost the market growth. Bioresorbable implants degrade after completion of its function, which is considered as the major advantage of bioresorbable implants over the permanently installed devices. Bioresorbable implants also bypasses the need of second surgery for the removal of the implant, making the process cost effective as compared to the non-biodegradable implants. However, bare metal implants or inert metallic implants lead to serious and life threating conditions such as neoatherosclerosis, late stent thrombosis, and local inflammation due to the presence of a foreign body.
Key features of the study:
This report provides in-depth analysis of the bioresorbable implants market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global bioresorbable implants market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Bioretec Ltd., CONMED Corporation, Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew Plc., and Boston Scientific Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global bioresorbable implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bioresorbable implants market
Detailed Segmentation:
Global Bioresorbable Implants Market, By Material Type:
Metallic
Polymer
PLGA- Poly lactic-co-glycolic acid
PLLA- Poly L-lactide
PGA- Polyglycolic Acid
PLA- Polylactic Acid
Others
Global Bioresorbable Implants Market, By Application:
Orthopedic
Cardiovascular
Others
Global Bioresorbable Implants Market, By End User:
Hospitals
Ambulatory Surgical Centers
Others
Global Bioresorbable Implants Market, By Geography:
North America
By Material Type:
Metallic
Polymer
PLGA- Poly lactic-co-glycolic acid
PLLA- Poly L-lactide
PGA- Polyglycolic Acid
PLA- Polylactic Acid
Others
By Application:
Orthopedic
Cardiovascular
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
U.S.
Canada
Latin America
By Material Type:
Metallic
Polymer
PLGA- Poly lactic-co-glycolic acid
PLLA- Poly L-lactide
PGA- Polyglycolic Acid
PLA- Polylactic Acid
Others
By Application:
Orthopedic
Cardiovascular
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Material Type:
Metallic
Polymer
PLGA- Poly lactic-co-glycolic acid
PLLA- Poly L-lactide
PGA- Polyglycolic Acid
PLA- Polylactic Acid
Others
By Application:
Orthopedic
Cardiovascular
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Material Type:
Metallic
Polymer
PLGA- Poly lactic-co-glycolic acid
PLLA- Poly L-lactide
PGA- Polyglycolic Acid
PLA- Polylactic Acid
Others
By Application:
Orthopedic
Cardiovascular
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Material Type:
Metallic
Polymer
PLGA- Poly lactic-co-glycolic acid
PLLA- Poly L-lactide
PGA- Polyglycolic Acid
PLA- Polylactic Acid
Others
By Application:
Orthopedic
Cardiovascular
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
Ambulatory Surgical Centers
Specialty Clinics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Material Type:
Metallic
Polymer
PLGA- Poly lactic-co-glycolic acid
PLLA- Poly L-lactide
PGA- Polyglycolic Acid
PLA- Polylactic Acid
Others
By Application:
Orthopedic
Cardiovascular
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Bioretec Ltd. *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
CONMED Corporation
Depuy Synthes
Stryker Corporation
Smith & Nephew Plc.
Zimmer Biomet Holdings Inc.
Boston Scientific Corporation
“*” marked represents similar segmentation in other categories in the respective section.